ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
生物医药B类股
492.301
-8.510
-1.70%
手动刷新
涨家数:
3
跌家数:
27
平家数:
3
市盈率:
- -
高:
501.068
开:
501.068
低:
481.557
收:
500.811
成交量:
7,406.45万
成交额:
19.55亿
市值:
3,109.35亿
流通市值:
2,788.25亿
数据加载中...
总览
新闻资讯
港股午评|恒生指数早盘跌0.04% CRO概念股涨幅居前
智通财经
·
09/30
记者观察| MNC抢筹 A股投资者对创新药为什么不买账?
中国经营报
·
09/30
科创50指数半日跌超2%,创新药、CRO概念股集体走强,房地产板块震荡回升
东方财富网
·
09/30
疫苗概念股早盘走高,疫苗、创新药相关ETF涨超3%
东方财富网
·
09/30
港股三大指数拉升转涨
格隆汇
·
09/30
医药大牛股涨超12%,创历史新高
东方财富网
·
09/30
创新药概念普涨 金斯瑞生物科技(01548)涨超10% 机构看好创新药及其产业链
金吾财讯
·
09/30
和铂医药-B(02142)股价上升5.022%,现价港币$14.22
阿斯达克财经
·
09/30
港股医药逆市独舞!AI制药再扛旗,金斯瑞飙逾9%再创新高,港股通医疗ETF华宝(159137)标的指数涨超2%
新浪基金
·
09/30
启明医疗-B(02500)股价上升5.106%,现价港币$1.235
阿斯达克财经
·
09/30
港股异动 | 泰格医药(03347)盘中涨超4% 与迪安诊断签署战略合作协议 将围绕AI制药等多领域开展深度合作
智通财经
·
09/30
港股异动 | mRNA概念股涨幅居前 康希诺生物(06185)涨超17% 莫德纳mRNA新抗原疗法将亮相ESMO大会
智通财经
·
09/30
康希诺生物(06185)股价显著上升14.341%,现价港币$35.56
阿斯达克财经
·
09/30
康方生物(09926)出现大手卖出29.6万股,成交价$102.1,涉资3.022千万
阿斯达克财经
·
09/30
诺和诺德26亿美元买下恒瑞医药周口服减肥药;阿斯利康将出资20亿美元战略投资Summit丨医药早参
每日经济新闻
·
09/30
合作方迎来跨国巨头20亿美元投资 康方生物依沃西单抗能成为“重磅炸弹”吗?
每日经济新闻
·
09/29
上海莱士总经理回应收购勃林格殷格翰上海生产基地:我们确实在加大创新药投入,但远未到押上家底的程度
同花顺
·
09/29
智通港股解盘 | 居民贴息利好发布地产大涨 创新药密集催化
智通财经
·
09/29
医药“十五五”规划落地,科创板创新药、医疗器械迎政策利好
东方财富网
·
09/29
Ourea Biotech HK Limited减持劲方医药-B(02595)600万股 每股作价27.3港元
智通财经
·
09/29
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BK1574/news?page=11"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":492.301,"timestamp":1791878906339,"preClose":500.8114,"halted":0,"volume":74064459,"delay":0,"changeRate":-0.016993,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-8.510406,"latestTime":"10-13 16:00:00","open":501.06766,"high":501.06766,"low":481.5568,"amount":1955398739.5,"amplitude":0.038959,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"pbRate":3.724844,"peRate":165.446177,"turnoverRate":0.002775,"increases":3,"decrements":26,"flats":3,"marketCap":310934550112,"floatMarketCap":278824693896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":501.06766,"amplitude":0.038959,"preClose":500.8114,"low":481.5568,"pbRate":"3.724844","latestPrice":492.301,"volume":74064459,"delay":0,"open":501.06766,"prevYearClose":556.26263,"prevWeekClose":503.547,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":534.856,"twentyDayClose":502.512,"sixtyDayClose":494.234,"secType":"PLATE","market":"HK","turnoverRate":0.002775,"peRate":165.446177,"marketCap":310934550112,"floatMarketCap":278824693896,"timestamp":1791878906339,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":3,"down":27,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:11,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671222053","title":"港股午评|恒生指数早盘跌0.04% CRO概念股涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222053","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222053?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 12:00","pubTimestamp":1790740842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数跌0.04%,跌10个点,报24513点;恒生科技指数跌0.15%。港股早盘成交887亿港元。mRNA概念股涨幅居前。CRO概念股涨幅居前,BD高增叠加湿实验需求升温,行业景气度上行信号明确。泰格医药涨超4%,与迪安诊断签署战略合作协议,将围绕AI制药等多领域开展深度合作。地产港股盘中V型反转,万科企业一度跌超11%,午盘涨超2%。汇量科技涨超8%,AI Infra升级有望进一步提升算法效率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRNX","513600","MCHmain","BK1594","BK1515","IDNA","MRNA","GNOM","00625","03115","BK1524","BK1191","BK1161","BK4551","HSI","688185","LU1188198961.HKD","BK1206","BK4588","07552","BK4533","BK1555","HK0000306701.USD","LU1831875114.USD","02837","BK1141","IE0034224299.USD","07500","BK1576","02362","LGHT","BK1518","002821","BK1544","BK1137","BK4548","HSTECH","BK1507","06127","07300","600547","LU0326950275.SGD","01787","02202","02800","07200","BK1583","URNJ","01860","BK1521","BK1240","03347","WDNA","01164","MRNY","BK1613","03067","09088","300347","HK0000320264.USD","603127","06821","HK0000306685.HKD","BK4501","03417","02833","09115","BK4534","BK1198","03033","000002","LU0140636845.USD","06185","02723","BK1178","07226","LU0828237940.HKD","BK4585","BK1592","03419","LU0244354667.USD","03037","BK1590","01548","83115","03088","HK0000320223.HKD","06802","LU0181495838.USD","03423","HHImain","82800","03032","BK4568","BK1586","09067","BK4532","BK1574","BK4139","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222707","title":"记者观察| MNC抢筹 A股投资者对创新药为什么不买账?","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222707","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222707?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 11:42","pubTimestamp":1790739750,"startTime":"0","endTime":"0","summary":"9月28日晚,思璞锐一款临床前管线BD(业务拓展)引爆朋友圈——阿斯利康首付4亿美元引进。不到24小时,恒瑞医药宣布其GLP-1/GIP双受体激动剂临床前管线以3亿美元首付授权出海,买家是诺和诺德。短短两天,7亿美元,两笔交易,创新药“早期研发—海外授权”的商业模式正被验证为一条可复制的通路。但热闹的另一面是市场的冷眼旁观。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609303887561973.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609303887561973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02827","BK1161","159982","BK1574","07233","82843","BK1610","06978","82823","IBBQ","LNGR","02843","159992","83130","82822","03188","82846","02846","83188","02823","399300","02822","BK1147","03130","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671227047","title":"科创50指数半日跌超2%,创新药、CRO概念股集体走强,房地产板块震荡回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2671227047","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671227047?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 11:35","pubTimestamp":1790739345,"startTime":"0","endTime":"0","summary":"【科创50指数半日跌超2%,创新药、CRO概念股集体走强】9月30日,A股三大指数午间收盘涨跌不一,沪指红盘震荡,创业板指高开回落翻绿。沪深两市半日成交额9093亿,较上个交易日放量331亿。全市场超2700只个股下跌。盘面上,题材快速轮动,创新药、CRO概念走强,康希诺、泰诺麦博20CM涨停,美诺华、康辰药业涨停;机器人襄阳轴承4连板,宁波东力、龙溪股份涨停;固态电池紫竹高科、传艺科技、上海洗霸均走出2连板;汽车松芝股份、松原安全涨停;房地产板块日内震荡回升,中天服务、陆家嘴涨停,深物业A上演“地天板”。下跌方面,半导体产业链震荡调整,芯原股份跌超10%,康强电子、燧原科技、华峰测控等纷纷下挫。截至收盘,沪指涨0.27%,深成指跌0.06%,创业板指跌0.17%,科创50指数跌2.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/1407,202609303887560410.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/1407,202609303887560410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["IBBQ","BK1161","MEDX","LNGR","XMLV","159371","BK1574","XRLV","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222223","title":"疫苗概念股早盘走高,疫苗、创新药相关ETF涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222223","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222223?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 11:00","pubTimestamp":1790737215,"startTime":"0","endTime":"0","summary":"疫苗概念股早盘走高,昭衍新药涨超7%,沃森生物涨超6%,智飞生物涨超4%。受盘面影响,疫苗、创新药相关ETF涨超3%。从政策与需求端看,流感疫苗“四价转三价”的落地与接种旺季启动有望形成共振,短期有望对流感疫苗企业的批签发节奏和终端动销形成阶段性催化,但产品结构切换过程中的渠道去库存与定价调整仍需跟踪。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202609303887543643.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202609303887543643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK4585","159992","MEDX","BK4588","FDN","06978","159646","LNGR","BK1161","BK4550","IBBQ","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671934224","title":"港股三大指数拉升转涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2671934224","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671934224?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:57","pubTimestamp":1790737054,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0008368742.USD","BK1583","IE00B5MMRT66.SGD","LU0359201612.USD","LU1023057109.AUD","LU2543165471.USD","LU0314109678.HKD","LU1807302812.USD","KURE","LU0315179316.USD","LU0326950275.SGD","LU0359202008.SGD","LU1226287875.USD","BK1574","HK0000165453.HKD","IE00B031HY20.USD","01276","BK1515","LU1960683339.HKD","BK1521","LU1226287529.USD","LU1328277881.USD","LU0067412154.USD","LU1226288253.USD","BK1191","LU1813983027.USD","LU0880133367.SGD","LU1993786604.SGD","LU2039709279.SGD","LU1951186391.HKD","LU0140636845.USD","IE00BZ08YT58.USD","01952","IE00BZ08YR35.GBP","SG9999004220.SGD","06978","LU1152091754.HKD","LU0359201885.HKD","LU1152091168.USD","LU0072913022.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1226288170.HKD","BK1161","IE0008369823.USD","LU1226287792.SGD","LU1008478684.HKD","IE00B543WZ88.USD","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224911","title":"医药大牛股涨超12%,创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224911","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224911?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:48","pubTimestamp":1790736506,"startTime":"0","endTime":"0","summary":"今天上午盘中,医药股走强,生物制品、重组蛋白、创新药等板块上涨。人气股近岸蛋白盘中涨超12%,股价创历史新高,最新市值超110亿元。今年以来,近岸蛋白的股价累计涨幅已接近300%。兴业证券表示,近两年中国创新药对外授权交易数量及金额持续创新高,BD(商务拓展)产品逐步进入海外实质性兑现期,后续海外关键临床推进、上市销售及商业化分成有望持续提升产品潜在销售峰值与成功率。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202609303887536226.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202609303887536226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK1161","BK1574","09939","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222418","title":"创新药概念普涨 金斯瑞生物科技(01548)涨超10% 机构看好创新药及其产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222418","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222418?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:35","pubTimestamp":1790735739,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念普涨,截至发稿,金斯瑞生物科技 涨10.10%,石药集团涨6.07%,云顶新耀涨5.79%,恒瑞医药涨5.18%,药明合联涨4.48%,晶泰控股涨4.06%,乐普生物涨3.52%,药明生物涨3.46%。消息面上,开源证券表示,整体上,持续看好创新药及其产业链及AI、脑机接口、生物制造等国家战略新兴产业。后续可重点跟踪ESMO临床数据、三季度订单及业绩验证和政策细则落地,积极把握优质创新药、CXO及生命科学上游调整后的配置机会。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992823","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","IBBQ","IE00B0JY6N72.USD","01276","LU0307460666.USD","BK1610","BK1521","LU0516422366.SGD","LU1188198961.HKD","LU1226288170.HKD","01548","01093","IE00BZ08YR35.GBP","BK1574","02269","LNGR","LU1813983027.USD","BK1515","KURE","BK1589","IE00BZ08YT58.USD","02228","LU0029874905.USD","BK1141","BK1161","SG9999004220.SGD","LU0072913022.USD","HK0000306701.USD","LU0540923850.HKD","LU0140636845.USD","01952","LU1688375341.USD","LU0880133367.SGD","LU0128522744.USD","LU1328277881.USD","LU1807302812.USD","LU0359201885.HKD","02157","LU1880383366.USD","159992","06978","LU0708995153.HKD","LU0823426480.USD","LU1242518931.SGD","MEDX","LU1242518857.USD","LU0181495838.USD","02268","LU1008478684.HKD","LU0039217434.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246882","title":"和铂医药-B(02142)股价上升5.022%,现价港币$14.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246882","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246882?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:35","pubTimestamp":1790735700,"startTime":"0","endTime":"0","summary":"[上升股]和铂医药-B(02142) 股价在上午10:35比前收市价上升5.022%,现股价为港币$14.22。至目前为止,今日最高价为$14.22,而最低价为$13.58。总成交量为277.7万股,总成交金额为港币$3.889千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144025903_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144025903_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260930701/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260930701/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","BK1583","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221725","title":"港股医药逆市独舞!AI制药再扛旗,金斯瑞飙逾9%再创新高,港股通医疗ETF华宝(159137)标的指数涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221725","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671221725?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:29","pubTimestamp":1790735340,"startTime":"0","endTime":"0","summary":"9月30日,港股医药独立行情继续上演!","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-30/doc-initqkpm5811024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159137","159718","QTOC","ARTY","01477","AGIX","BK1191","CHAT","FLHK","VTHR","KURE","AIPO","512170","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224802","title":"启明医疗-B(02500)股价上升5.106%,现价港币$1.235","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224802","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224802?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:25","pubTimestamp":1790735100,"startTime":"0","endTime":"0","summary":"[上升股]启明医疗-B(02500) 股价在上午10:25比前收市价上升5.106%,现股价为港币$1.235。至目前为止,今日最高价为$1.235,而最低价为$1.17。总成交量为10.2万股,总成交金额为港币$12.022万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260930645/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260930645/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1100","02500","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221261","title":"港股异动 | 泰格医药(03347)盘中涨超4% 与迪安诊断签署战略合作协议 将围绕AI制药等多领域开展深度合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221261","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671221261?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:13","pubTimestamp":1790734418,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,泰格医药盘中涨超4%,截至发稿,涨3.63%,报47港元,成交额1976.94万港元。消息面上,据泰格医药官微消息,近日,泰格医药与迪安诊断在杭州签署战略合作协议。双方将围绕AI制药、临床试验、伴随诊断等领域开展深度合作,共同构建国内领先的“创新药研发—伴随诊断”一体化协同体系,让诊断与数据能力更早融入药物研发过程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1820825898.SGD","AGIX","BK0028","300347","BK1141","BK1576","VXUS","BK1574","BK0174","CHAT","KCAI","LU1146622755.USD","BK0236","BK1191","BK0186","QTOC","300244","BK0070","AIPO","BK0114","BK0216","VTHR","BK0042","BK0197","ARTY","BK4588","01477","03347","BK4585","BK1583","BK0146","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671822138","title":"港股异动 | mRNA概念股涨幅居前 康希诺生物(06185)涨超17% 莫德纳mRNA新抗原疗法将亮相ESMO大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2671822138","media":"智通财经","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671822138?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 09:47","pubTimestamp":1790732842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,mRNA概念股涨幅居前,截至发稿,康希诺生物涨16.78%,报36.32港元;云顶新耀涨4.29%,报29.18港元;思路迪医药股份涨1.94%,报2.89港元;剂泰科技-P涨1.44%,报16.22港元。值得注意的是,8月25日,康希诺生物与德普世生物签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》。此前在mRNA领域,康希诺生物已布局mRNA 疫苗用于胶质母细胞瘤、横纹肌肉瘤及宫颈癌等适应症的研发。云顶新耀计划在2026年第四季度开展对mRNA疫苗EVM16的 IIT Ib研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK1161","07666","01952","VXUS","BK1191","BK1574","BK1583","01244","06185","BK4588","BK1515","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671229227","title":"康希诺生物(06185)股价显著上升14.341%,现价港币$35.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2671229227","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671229227?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 09:35","pubTimestamp":1790732100,"startTime":"0","endTime":"0","summary":"[上升股]康希诺生物(06185) 股价在上午09:35比前收市价显著上升14.341%,现股价为港币$35.56。至目前为止,今日最高价为$35.56,而最低价为$31.12。总成交量为146.32万股,总成交金额为港币$4.939千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144023737_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144023737_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260930224/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260930224/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1191","BK1574","06185","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671022965","title":"康方生物(09926)出现大手卖出29.6万股,成交价$102.1,涉资3.022千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2671022965","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671022965?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 09:20","pubTimestamp":1790731200,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在上午09:20出现大手卖出,成交量为29.6万,成交价为港币$102.1,涉资3.022千万。至目前为止,股价跌3.951%,今日最高价为$102.1,而最低价为$102.1,总成交量为100.4万股,总成交金额港币$1.054亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26093048/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26093048/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00BPRC5H50.USD","LU1794554557.SGD","LU2476274720.SGD","BK1161","LU0348767384.USD","LU2778985437.USD","LU0540923850.HKD","LU0348827113.USD","LU0561508036.HKD","LU0348766576.USD","LU0417516902.SGD","IE00B5MMRT66.SGD","LU1961090484.USD","LU2399975544.HKD","BK1574","LU2488822045.USD","LU0348825331.USD","LU2476274308.USD","09926","KURE","LU0348783233.USD","LU0348784397.USD","LU0634319403.HKD","LU1720050803.USD","LU0348735423.USD","IE00B543WZ88.USD","LU0417516738.SGD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671773228","title":"诺和诺德26亿美元买下恒瑞医药周口服减肥药;阿斯利康将出资20亿美元战略投资Summit丨医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2671773228","media":"每日经济新闻","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671773228?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 07:00","pubTimestamp":1790722804,"startTime":"0","endTime":"0","summary":"丨2026年9月30日星期三丨NO.1恒瑞医药:将周口服减肥药许可给诺和诺德,潜在总交易额最高可达26亿美元9月29日,恒瑞医药公告称,与诺和诺德达成协议,将恒瑞潜在每周一次口服给药的胰高血糖素样肽-1(GLP-1)和抑胃肽(GIP)双受体激动剂HRS-1596有偿许可给诺和诺德。诺和诺德将获得HRS-1596在大中华地区以外的全球范围内开发、生产和商业化的独家权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609303886886698.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609303886886698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","LU0405327494.USD","LU2580892789.USD","LU0405327148.USD","LU1064131003.USD","LU1820825898.SGD","BK1574","LU1997245177.USD","LU0359202008.SGD","LU1997244956.HKD","LU2148510915.USD","LU2097828631.EUR","LU2495084118.USD","BK1515","LU0359201612.USD","LU1255011170.USD","LU2289578879.USD","LU1328615791.USD","LU0359201885.HKD","LU1023057109.AUD","THNR","01276","BK0012","159938","LU1655091616.SGD","LU2097828805.USD","LU1969619763.USD","BK1191","BK0196","BGIA","09939","LU2097828714.EUR","BK0239","LU2328871848.SGD","LU1064130708.USD","LU1580142542.USD","LU2097828474.EUR","LU2097828557.USD","LU2543165471.USD","LU1146622755.USD","BK0188","LU1997245094.SGD","LU2580892862.HKD","600276","LU1781817850.SGD","LU2488822045.USD","BK0183","BK1161","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671243561","title":"合作方迎来跨国巨头20亿美元投资 康方生物依沃西单抗能成为“重磅炸弹”吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2671243561","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671243561?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 22:43","pubTimestamp":1790693010,"startTime":"0","endTime":"0","summary":"9月29日早间,康方生物在微信公众号上发布消息,阿斯利康以20亿美元认购SummitTherapeutics(以下简称Summit)新发行的可转换优先股,折合每股18.36美元。同时双方围绕PD-1/VEGF双抗依沃西单抗(AK112)与阿斯利康ADC(抗体偶联药物)管线建立临床合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609293886797868.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609293886797868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0348735423.USD","LU0417516902.SGD","LU0348784397.USD","LU1961090484.USD","LU0540923850.HKD","LU1720050803.USD","09926","LU0348827113.USD","BK1161","LU2476274308.USD","LU2399975544.HKD","LU0561508036.HKD","LU0634319403.HKD","BK1574","LU0417516738.SGD","LU2476274720.SGD","IE00BPRC5H50.USD","LU1794554557.SGD","IE00B543WZ88.USD","LU2488822045.USD","LU0348767384.USD","LU0417516571.SGD","LU2778985437.USD","LU0348825331.USD","KURE","LU0348783233.USD","LU0348766576.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248079","title":"上海莱士总经理回应收购勃林格殷格翰上海生产基地:我们确实在加大创新药投入,但远未到押上家底的程度","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248079","media":"同花顺","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671248079?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 22:42","pubTimestamp":1790692920,"startTime":"0","endTime":"0","summary":"“是战略卡位,补齐创新药产业化能力。”9月28日,上海莱士(SZ002252,股价5.17元,总市值340.84亿元)副董事长、总经理徐俊在接受采访时回应道。一周前,上海莱士发布公告,拟以现金收购勃 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260929/c680380424.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260929/c680380424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["159992","BK0188","BK0196","LNGR","IBBQ","BK1161","BK1574","MEDX","BK0046","BK0028","BK0239","002252","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671143262","title":"智通港股解盘 | 居民贴息利好发布地产大涨 创新药密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2671143262","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671143262?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 20:26","pubTimestamp":1790684766,"startTime":"0","endTime":"0","summary":"美伊之间继续谈判,两国官员表示,美国与伊朗官员周一分别与调解方进行了会谈,重新努力结束这场持续七个月的战争。公司预计将在2028财年之前执行该回购计划。全球前十大Tier 1汽车供应商中有八家是公司的客户,公司的PCB产品已广泛应用于全球前十大汽车集团的汽车产品中。9月28日,上海证券交易所发布《关于沪港通下港股通标的调整的通知》。调入景旺电子,并自下一港股通交易日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502248.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SGXZ86797644.SGD","SG9999014674.SGD","LU0082770016.SGD","SG9999003461.SGD","03996","BK1529","LU0164939612.USD","BK4585","BK1555","BK4588","BK1105","SG9999001069.SGD","BK1161","LU0082770016.USD","IE00B031HY20.USD","VXUS","IE0008368742.USD","03301","MEDX","KCAI","LU0052750758.USD","SGXZ62798434.SGD","BK1148","03393","00552","02128","IBBQ","BK1574","IE0008369823.USD","159992","LU0708995583.HKD","SG9999002950.SGD","01081","BK1506","06978","BK1179","LNGR","BK1240","LU0620787316.HKD","BK1205","LU1808992512.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211883","title":"医药“十五五”规划落地,科创板创新药、医疗器械迎政策利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211883","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211883?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:41","pubTimestamp":1790682114,"startTime":"0","endTime":"0","summary":"近日,工业和信息化部等十部门联合印发《医药工业发展“十五五”规划》(以下简称《规划》),对“十五五”时期我国医药工业高质量发展作出系统性部署。《规划》围绕创新驱动、韧性安全、数智转型等八大方向部署25项重点任务,为创新药、医疗器械等细分行业进一步明确了长期发展路线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202609293886609720.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202609293886609720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["159938","IBBQ","IEIH","PTH","09939","BK1515","GDOC","BK1100","RSPH","159883","09996","BK1583","HART","KSTR","MDEV","BK1161","MEDX","159992","LGHT","06978","LNGR","BK1574","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671747216","title":"Ourea Biotech HK Limited减持劲方医药-B(02595)600万股 每股作价27.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671747216","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671747216?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:15","pubTimestamp":1790680502,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,9月24日,Ourea Biotech HK Limited减持劲方医药-B600万股,每股作价27.3港元,总金额为1.638亿港元。减持后最新持股数目约为1630.69万股,最新持股比例为4.64%。本交易涉及其他关联方:HL GP II Company Limited、HL Partners II L.P.补充资料:Ourea Biotech由HL Partners II L.P.控制,而HL Partners II L.P.是一家根据开曼群岛法律成立的有限合伙企业,最终由其普通合伙人HL GP II Company Limited管理。因此,根据证券及期货条例,HL Partners II L.P.及HL GP II Company Limited各自被视为于Ourea Biotech所持股份中拥有权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","XBI","09939","BK4585","159938","BK4588","EWH","02595","BK4581","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":11,"totalSize":226,"code":"91000000","status":"200"}]}}